They're Baaaaaack!

Once again, FDA is meeting to discuss direct-to-consumer genetic tests, reports Genomics Law Report's Dan Vorhaus. In one month, the regulatory body's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will hold a public meeting to discuss the scientific issues surrounding DTC tests that make medical claims, Vorhaus says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.